Cargando…

Response to the Article on Antibiotics and Immune Checkpoint Inhibitors by Lin et al.

Detalles Bibliográficos
Autores principales:	Cheung, Ka Shing, Leung, Wai K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Reply
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801173/ https://www.ncbi.nlm.nih.gov/pubmed/36589730 http://dx.doi.org/10.1159/000526003

Ejemplares similares

Antibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status
por: Cheung, Ka Shing, et al.
Publicado: (2022)

Response to Comments by Vuksan V. et al., Nutrients 2017, 9, 398, Regarding an Article by Solah V.A. et al., Nutrients 2017, 9, 149
por: Solah, Vicky A., et al.
Publicado: (2017)

Response to Dr. Moya’s Comments to Article by Thoene M et al., Nutrients 2016, 8, 451
por: Thoene, Melissa, et al.
Publicado: (2016)

Response to Letter to Editor by Dr. Aminnejad et al.
por: Shahrokhirad, Reyhaneh, et al.
Publicado: (2019)

Response to: gender differences on neuromuscular strategy during drop jump: a comment on Helm et al. (2019) by Di Giminiani et al.
por: Helm, M., et al.
Publicado: (2020)

Reply to Zarguan et al. Comment on “Budryn et al. Hydroxybenzoic Acids as Acetylcholinesterase Inhibitors: Calorimetric and Docking Simulation Studies. Nutrients 2022, 14, 2476”
por: Grzelczyk, Joanna, et al.
Publicado: (2022)

Reply to De Giorgi et al. Comment on “Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822”
por: Kesić, Vesna, et al.
Publicado: (2022)

Comment on Gomez et. al. “Response to article by Wasserman et. al. (2018) ‘Modelling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico’”
por: Wasserman, Matt, et al.
Publicado: (2019)

Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554
por: Macek Jilkova, Zuzana, et al.
Publicado: (2020)

Reply to Kovacs et al.: Concerning acute inflammatory response following focused ultrasound and microbubbles in the brain
por: McMahon, Dallan, et al.
Publicado: (2018)

Response to van Dyck, O'Dell, & Mecca letter to the editor regarding Andrews et al. (2019)
por: Andrews, J. Scott, et al.
Publicado: (2023)

Response to a Comment by Albert et al. (Nutrients 2017, 9, 137) Entitled “Concerns with the Study on Australian and New Zealand Fish Oil Products” by Nichols et al. (Nutrients 2016, 8, 703)
por: Nichols, Peter D., et al.
Publicado: (2017)

Reply to Abenavoli et al. Comment on “Clayton-Chubb et al. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023, 15, 687”
por: Clayton-Chubb, Daniel, et al.
Publicado: (2023)

Reply to Aguenaou et al. Comment on “Muzzioli et al. Are Front-of-Pack Labels a Health Policy Tool? Nutrients 2022, 14, 771”
por: Muzzioli, Luca, et al.
Publicado: (2022)

Reply to Vrijdag et al. Comment on “Mankowska et al. Critical Flicker Fusion Frequency: A Narrative Review. Medicina 2021, 57, 1096”
por: Mankowska, Natalia D., et al.
Publicado: (2022)

Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
por: Boelaert, Jente, et al.
Publicado: (2016)

Response to Wilson et al. Comments on Lopez-Jaramillo et al. DivinylSulfone Cross-Linked Cyclodextrin-Based Polymeric Materials: Synthesis and Applications as Sorbents and Encapsulating Agents. Molecules, 2015, 20, 3565–3581.
por: Lopez-Jaramillo, Francisco Javier, et al.
Publicado: (2016)

Reply to Witthöft et al. Comment on “Wardzinski et al. Mobile Phone Radiation Deflects Brain Energy Homeostasis and Prompts Human Food Ingestion. Nutrients 2022, 14, 339”
por: Wardzinski, Ewelina K., et al.
Publicado: (2022)

Reply to Bracke et al. Comment on “Prayag et al. Light Modulation of Human Clocks, Wake, and Sleep. Clocks&Sleep 2019, 1, 193–208”
por: Prayag, Abhishek S., et al.
Publicado: (2021)

Reply to van der Pluijm et al. Comment on “Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781”
por: Calfon-Peretz, Ortal, et al.
Publicado: (2022)

Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”
por: Ramai, Daryl, et al.
Publicado: (2023)

Response to Madans et al. Comments on Sabariego et al. Measuring Disability: Comparing the Impact of Two Data Collection Approaches on Disability Rates. Int. J. Environ. Res. Public Health, 2015, 12, 10329–10351
por: Sabariego, Carla, et al.
Publicado: (2015)

Response to Ponamgi et al. Comments on Khalighi et al. Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction. J. Cardiovasc. Dev. Dis., 2015, 2, 273–281.
por: Farooq, Mohammad Umar, et al.
Publicado: (2016)

Reply to Chaudhuri et al. Comment on “Balwierz et al. Potential Carcinogens in Makeup Cosmetics. Int. J. Environ. Res. Public Health 2023, 20, 4780”
por: Balwierz, Radosław, et al.
Publicado: (2023)

Reply to Taylor et al. Comment on “Manna et al. SARS-CoV-2 Inactivation in Aerosol by Means of Radiated Microwaves. Viruses 2023, 15, 1443”
por: Manna, Antonio, et al.
Publicado: (2023)

Response to Polosa et al. Comments on Scheffler et al. Cytotoxic Evaluation of E-Liquid Aerosol Using Different Lung Derived Cell Models. Int. J. Environ. Res. Public Health, 2015, 12, 12466-12474
por: Scheffler, Stefanie, et al.
Publicado: (2016)

Response to Martinez-Novack et al. Comments on Hynes et al. Prevalence of Marijuana Use among University Students in Bolivia, Colombia, Ecuador, and Peru. Int. J. Environ. Res. Public Health, 2015, 12, 5233-5240
por: Hynes, Marya, et al.
Publicado: (2015)

Response to García-Nieto et al. Comments on Beamer et al. Association of Children’s Urinary CC16 Levels with Arsenic Concentrations in Multiple Environmental Media. Int. J. Environ. Res. Public Health 2016, 13, 521
por: Beamer, Paloma I., et al.
Publicado: (2016)

Revision of J3Gen Validity of the Attacks by Peinado et al.
por: Peinado, Alberto, et al.
Publicado: (2015)

Reply to Dhawan et al. Comment on “Kim et al. The Association between Coffee Consumption and Risk of Colorectal Cancer in a Korean Population. Nutrients 2021, 13, 2753”
por: Kim, Youngyo, et al.
Publicado: (2021)

Reply to Campbell et al. Comment on “Hogas et al. Salt, Not Always a Cardiovascular Enemy? A Mini-Review and Modern Perspective. Medicina 2022, 58, 1175”
por: Hogas, Mihai, et al.
Publicado: (2022)

Reply to Mankowska et al. Comment on “Muth et al. Assessing Critical Flicker Fusion Frequency: Which Confounders? A Narrative Review. Medicina 2023, 59, 800”
por: Muth, Thomas, et al.
Publicado: (2023)

Response to Crespo et al. Comments on: Varela-Mato, V.; et al. Lifestyle and Health among Spanish University Students: Differences by Gender and Academic Discipline. Int. J. Environ. Res. Public Health 2012, 9, 2728–2741
por: Varela-Mato, Veronica
Publicado: (2013)

Reply to Freckmann et al. Comment on “Hochfellner et al. Accuracy Assessment of the GlucoMen(®) Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study. Biosensors 2022, 12, 106”
por: Hochfellner, Daniel A., et al.
Publicado: (2023)

Reply to Twycross et al. Comment on “Ramos-Rincon et al. Palliative Sedation in COVID-19 End-of-Life Care. Retrospective Cohort Study. Medicina 2021, 57, 873”
por: Ramos-Rincon, Jose-Manuel, et al.
Publicado: (2022)

Reply to Kielb et al. Untapped Potential for Female Patients? Comment on “Lucà et al. Update on Management of Cardiovascular Diseases in Women. J. Clin. Med. 2022, 11, 1176”
por: Lucà, Fabiana, et al.
Publicado: (2022)

Reply to Alt et al. Comment on “Lunz et al. Impact and Modification of the New PJI-TNM Classification for Periprosthetic Joint Infections. J. Clin. Med. 2023, 12, 1262”
por: Lunz, Andre, et al.
Publicado: (2023)

Reply to Auclin et al. Comment on “Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176”
por: Hopkins, Ashley M., et al.
Publicado: (2021)

Hering Hermeneutics: Supplement to Translation and Commentary of Hering (1899) by Strasburger et al.
por: Westheimer, Gerald
Publicado: (2018)

Reply to Neupane et al.: Replication study of AD‐associated rare variants
por: Prokopenko, Dmitry, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pvipnpc2ha0gddcnqciptp8c0p